why choose us

First received: November 17, 2023

Clinical Trial: Implementing Fragmentomics Into Real World Screening IntervenTions to Evaluate Clinical Utility Among Individuals With Elevated Risk for Lung Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Lung Cancer

Study Type: INTERVENTIONAL


Official Title: Investigating the Clinical Utility of DELFI Evaluation of Lung Cancer

Brief Summary: The purpose of this study is to determine whether availability of a DNA Evaluation of Fragments for Early Interception (DELFI) Lung Cancer Screening Test to practicing physicians affects overall lung cancer screening rates among their patients who are recommended and eligible for screening based on 2021 United States Preventive Services Task Force (USPSTF) but are not up to date with it.DELFI hypothesized that patients in the care of physicians or practice groups who have the DELFI Lung Cancer Screening Test will…

Read more